United States· US:58411-856_47a7a718-ae9f-4001-e063-6294a90a8857
cle de peau BEAUTE PROTECTIVE LIP TREATMENT
A medicinal product containing avobenzone; octinoxate; octocrylene, registered in United States by SHISEIDO AMERICAS CORPORATION.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- AVOBENZONE; OCTINOXATE; OCTOCRYLENE
- Manufacturer
- SHISEIDO AMERICAS CORPORATION
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1158411856201 BOTTLE, GLASS in 1 BOX (58411-856-20) / 4 g in 1 BOTTLE, GLASS (58411-856-10)
- ndc1158411-856-20
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Avobenzone; octinoxate; octocrylene in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/4043cb9f-f8c7-4ea3-a934-42889caa04cb GET /v1/drugs/4043cb9f-f8c7-4ea3-a934-42889caa04cb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "TOPICAL",
"source": "ndc",
"strength": "100; 196; 120",
"substance": "AVOBENZONE; OCTINOXATE; OCTOCRYLENE",
"productndc": "58411-856",
"dosage_form": "EMULSION",
"dea_schedule": null,
"strength_unit": "mg/4g; mg/4g; mg/4g",
"application_number": "M020",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about avobenzone; octinoxate; octocrylene.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.